Browsing Tag
Cardiovascular disease
30 posts
How VERVE-102 could accelerate the transition from chronic lipid therapy to genomic medicine
Could VERVE-102 shift cholesterol treatment from chronic therapy to one-time gene editing? Explore Eli Lilly and Company’s genomic medicine strategy.
Why industry observers are watching Tenvie Therapeutics’ TNV262 biomarker readout in 2026
Tenvie Therapeutics’ TNV262 readout in 2026 could reshape obesity and cardiometabolic drug development. Read why markets are watching closely.
Can RNA interference expand beyond rare diseases through Tenaya–Alnylam cardiovascular research? (NASDAQ: ALNY, NASDAQ: TNYA)
Tenaya Therapeutics and Alnylam Pharmaceuticals partner to discover RNAi drug targets for cardiovascular disease. Read what this biotech deal could mean.
Could MediciNova’s MN-002 redefine how atherosclerosis is treated? Peer-reviewed study says yes
Learn how MediciNova’s MN-002 boosts macrophage cholesterol efflux and why scientists say it could transform atherosclerosis treatment.
Why is Novartis acquiring Tourmaline Bio—and how does pacibekitug fit into its cardiovascular pipeline?
Novartis is acquiring Tourmaline Bio in a $1.4B deal to advance pacibekitug, a promising anti-IL-6 therapy for atherosclerotic cardiovascular disease.
Understanding what tachycardia means and how a rapid heartbeat impacts your health
Discover what tachycardia is, what causes it, and how a fast heartbeat affects your heart health. Learn about types, symptoms, diagnosis, and treatment options.
Mended Hearts International Foundation to expand global cardiovascular patient advocacy from Geneva
Mended Hearts International Foundation launches in Geneva to drive global cardiovascular advocacy, peer support, and health policy reform through MHIN.
Lilly’s lepodisiran shows 94% reduction in lipoprotein(a), offering hope for cardiovascular risk management
Lilly’s lepodisiran slashed lipoprotein(a) by 94% in a Phase 2 trial. See how this breakthrough could change cardiovascular disease treatment.
Glenmark Pharmaceuticals expands cardiometabolic portfolio with new Empagliflozin drug launch
Glenmark Pharmaceuticals Ltd. has introduced Empagliflozin, a widely recognized SGLT2 inhibitor, in India under the brand name Glempa.…
Gene Hackman’s death confirmed as cardiovascular disease and Alzheimer’s, wife died from hantavirus
The cause of death of Academy Award-winning actor Gene Hackman and his wife, Betsy Arakawa, has been officially…